-
Edge Pharma, LLC Issues Voluntary Nationwide Recall of All Drug Products Due to Lack of Sterility Assurance
AmericanPharmaceuticalReview
December 10, 2021
Edge Pharma, LLC is voluntarily recalling all lots of all drugs compounded at Edge Pharma, LLC to the consumer level. All products are being recalled due to process issues that could lead to a lack of sterility assurance for products intended to be ...
-
Rallybio Corporation Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
firstwordpharma
August 03, 2021
Rallybio Corporation today announced the closing of its initial public offering of 7,130,000 shares of common stock, including the exercise in full by the underwriters of their option to purchase up to 930,000 additional shares of common stock.
-
HCW Biologics Inc. Announces Closing of $56.0 Million Initial Public Offering
firstwordpharma
July 23, 2021
HCW Biologics Inc. today announced the closing of its previously announced underwritten initial public offering of 7,000,000 shares of common stock at a public offering price of $8.00 per share for gross proceeds of $56.0 million
-
Novan Announces Closing of $40 Million Public Offering of Common Stock
firstwordpharma
June 22, 2021
Novan, Inc. (the "Company" or "Novan") (NASDAQ:NOVN) today announced the closing of the Company's previously announced underwritten public offering (the "Offering") of 3,636,364 shares of common stock at a public offering price of $11.00 per share.
-
Biohaven Appoints Kishen Mehta to Board of Directors
firstwordpharma
June 18, 2021
Biohaven Pharmaceutical Holding Company Ltd. today announced the appointment of Kishen Mehta, Portfolio Manager at Suvretta Capital Management, LLC, to its Board of Directors ("Board"). Mr. Mehta previously served as a strategic advisor to Biohaven.
-
Vertical Pharmaceuticals, LLC, an Osmotica Company, Announces Submission of New Drug Application for RVL-1201
drugs
September 23, 2019
Vertical Pharmaceuticals, LLC (a subsidiary of Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated biopharmaceutical company) ...
-
Pharm D Solutions, LLC Issues Voluntary Nationwide Recall of All Sterile Compounded Drugs Due to a Potential Lack of Sterility Assurance
drugs
June 10, 2019
Pharm D Solutions, LLC Issues Voluntary Nationwide Recall of All Sterile Compounded Drugs Due to a Potential Lack of Sterility Assurance.
-
Direct Biologics, LLC Has Acquired Paisley Laboratories, LLC
pharmafocusasia
December 03, 2018
DirectBiologics, LLC announces the acquisition of Paisley Laboratories, LLC. The mission of these combined research and development companies is to transform regenerative healing with an emphasis on improved patient care.
-
Innovus Pharmaceuticals Acquires Worldwide Rights to Four Products from Boston Topicals, LLC
pharmafocusasia
November 26, 2018
We continue to bolster our product pipeline with clinically and commercially validated products that fit both our direct to consumer channels as well as retail....
-
Caligor Holdco, LLC, Leader in Strategic Clinical Trial Services, Acquires The Coghlan Group
prnasia
November 17, 2017
Caligor Holdco, LLC., announced today the acquisition of The Coghlan Group, a leading materials management service company for clinical trials.